Search Orphan Drug Designations and Approvals
-
Generic Name: | trastuzumab |
---|---|
Date Designated: | 12/14/1999 |
Orphan Designation: | Treatment of patients with pancreatic cancer that overexpress p185HER2. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Genentech, Inc. 1 DNA Way South San Francisco, California 94080 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-